How to Qualify for GLP-1 Medication Online in 2026

What are GLP-1 medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed to treat type 2 diabetes that turned out to be remarkably effective for weight loss. The most well-known include semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro).

They work by mimicking a hormone that your body naturally produces after eating — one that signals fullness, slows gastric emptying, and reduces appetite. The result is that most people on GLP-1 medications find it significantly easier to eat less without feeling deprived. Clinical trials have shown average weight loss of 15–25% of body weight over 12–18 months, which is meaningfully higher than any previous non-surgical weight loss intervention.

The challenge: brand-name GLP-1 medications cost $900–$1,500 per month without insurance. That's where telehealth platforms offering compounded versions — using the same active ingredients at a fraction of the cost — have become the dominant access point for most patients in 2026.

Do you qualify? The standard criteria

Most telehealth providers and physicians use criteria based on FDA-approved guidelines for GLP-1 prescribing. A licensed clinician makes the final determination, but here's what the standard eligibility framework looks like:

Standard GLP-1 eligibility criteria

BMI 30 or higher

Qualifies for GLP-1 consideration regardless of other conditions

BMI 27–29.9 with a condition

Qualifies if you also have type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea

Age 18 or older

Most platforms require you to be an adult. Some have upper age considerations based on medical history.

Previous weight loss attempts

Most providers ask about prior diet and exercise efforts — not a hard requirement but part of the clinical picture

Your BMI is the most important single factor. If you don't know yours, you can calculate it easily: divide your weight in pounds by your height in inches squared, then multiply by 703. Or use any free online BMI calculator.

Who typically does not qualify

Personal or family history of medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
History of pancreatitis (some providers)
Current pregnancy or breastfeeding
Certain gastrointestinal conditions
BMI under 27 with no qualifying health conditions

These disqualifiers are screened during the intake questionnaire. A licensed physician reviews every application — if there are concerns, they'll discuss alternatives with you rather than simply rejecting your application.

How the online qualification process works

Getting evaluated for GLP-1 medication through a telehealth platform is considerably simpler than going through a traditional doctor's office. Here's the typical process:

Complete the online health intake Answer questions about your height, weight, medical history, current medications, and weight loss goals. This typically takes 5–10 minutes and is done entirely online.
Physician review A licensed clinician reviews your intake. Some platforms do this asynchronously (they review and respond within a few hours); others offer a brief video or phone consultation. Either way, a real human reviews your case.
Prescription decision If you're a good candidate, the physician issues a prescription for compounded semaglutide or tirzepatide at a starting dose. They'll also outline a dosing schedule that typically titrates up over several months.
Medication shipped to your door Your compounded GLP-1 medication is dispensed from an licensed compounding pharmacy and shipped directly to you, typically within 3–7 business days of your first order.
Ongoing monitoring and dose adjustment Good telehealth platforms include regular check-ins to monitor your progress, manage side effects, and adjust your dose as needed. This ongoing relationship is what separates legitimate platforms from simple prescription dispensaries.

What GLP-1 medication actually costs in 2026

Cost is the biggest barrier for most people — and also the biggest area of confusion. Here's an honest breakdown:

Option	Monthly cost	Notes
Brand-name Wegovy (semaglutide)	$900–$1,500	With insurance coverage it can be lower — but prior auth is often required and frequently denied
Brand-name Zepbound (tirzepatide)	$900–$1,300	Similar insurance challenges as Wegovy
Compounded semaglutide (telehealth)	$99–$249/mo	Same active ingredient, fraction of the cost — the dominant access point in 2026
Compounded tirzepatide (telehealth)	$149–$299/mo	Tirzepatide compounding more complex, slightly higher cost
Generic semaglutide (pharmacy)	Not widely available	Patent situation means true generics are not yet broadly available in the US

For most people without insurance coverage for GLP-1s — which is the majority — compounded semaglutide through a telehealth platform is the most practical option. At $99–$249 per month, it's 70–85% cheaper than the brand-name equivalent while using the same active ingredient.

What to look for in a GLP-1 telehealth provider

Not all platforms offering compounded GLP-1 medications are equal. Here's what separates legitimate providers from those cutting corners:

Real physician involvement: A licensed clinician should review your intake and make the prescription decision — not an automated system
licensed compounding pharmacy: Ask where the medication is compounded. Legitimate platforms use 503A or 503B compounding pharmacies operating under FDA oversight
Transparent pricing: All costs disclosed upfront with no surprise fees or subscription traps
Ongoing monitoring: Regular check-ins, dose adjustment support, and access to your provider if issues arise
Clear safety disclosures: Risks, contraindications, and side effects communicated clearly before you start

Ready to check your eligibility?

DirectMeds is our top-rated GLP-1 telehealth platform for 2026 — transparent pricing, real physician consultations, and compounded semaglutide and tirzepatide shipped nationwide. The eligibility check is free.

Check your GLP-1 eligibility — it's free →

Common questions about GLP-1 eligibility

Can I qualify if my BMI is under 30?

Yes — if your BMI is between 27 and 29.9 and you have at least one weight-related health condition (type 2 diabetes, hypertension, high cholesterol, or sleep apnea), you may qualify. The physician makes the final determination based on your full clinical picture.

Do I need lab work to get started?

Most telehealth platforms do not require lab work upfront to begin the intake process. Some may recommend or require baseline labs (blood glucose, thyroid function, etc.) before prescribing, depending on your health history. Your provider will advise you if labs are needed.

How long does it take to get approved and receive medication?

Most patients complete the intake in under 15 minutes. Physician review typically happens within a few hours to one business day. Once approved, medication is usually shipped within 1–3 business days and arrives within 3–7 days total from approval. Some platforms offer expedited shipping.

Is compounded semaglutide the same as Wegovy?

Compounded semaglutide contains the same active ingredient as Wegovy (semaglutide) but is not the same product. It is manufactured by a licensed compounding pharmacy to contain the identical active molecule, but it has not gone through the same FDA approval process as the finished brand-name drug. The clinical mechanism and expected outcomes are the same, but compounded versions carry different regulatory status. This is the standard trade-off for accessing GLP-1 therapy at dramatically lower cost.

What happens if I'm not approved?

If a physician determines you're not a good candidate for GLP-1 therapy, they'll typically explain why and may suggest alternative approaches. You won't be charged for a medication you don't receive. Some platforms will suggest other programs or refer you back to your primary care physician for further evaluation.

Can I use GLP-1 medications long-term?

Current research and clinical practice generally support long-term use of GLP-1 medications for appropriate candidates. Studies show that stopping the medication typically results in weight regain over time, which has led most obesity medicine specialists to view GLP-1 therapy as a long-term treatment rather than a short-term intervention. Discuss your long-term plan with your prescribing provider.

Next steps

If you meet the basic criteria — BMI 30+, or BMI 27+ with a qualifying health condition, and no major contraindications — the most straightforward next step is to complete a free eligibility check with a reputable telehealth platform. The process takes less than 15 minutes and puts a licensed physician in front of your case the same day.

Our top recommendation for most people is DirectMeds — transparent pricing, real physician oversight, and access to both compounded semaglutide and tirzepatide. See our full 2026 telehealth weight loss rankings for a complete comparison of all the platforms we've evaluated.

This article is for informational purposes only and does not constitute medical advice. Eligibility for GLP-1 medications is determined by a licensed healthcare provider based on your individual health history.